Purchase Order 75N95C24P00073
- Not listed
- This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Vector Biosystems, Inc. (doing business as Vector Biolabs), a for-profit biotechnology company that provides gene delivery products and services. The $16,120 contract is for the delivery of an AAV viral vector with an EF1a promotor expressing a green fluorescent protein. This contract supports NCATS' biomedical...
- This purchase order awards Vector Biosystems, Inc., doing business as Vector Biolabs, $12,060 to deliver two custom adeno-associated viral constructs to the National Center for Advancing Translational Sciences within the Department of Health and Human Services' National Institutes of Health. Specifically, Vector Biosystems will provide one AAV6 vector containing GFP and an shRNA targeting human COLQ, and one AAV6 vector containing GFP and an shRNA targeting human DOK7. Both constructs are to...
- This firm fixed-price purchase order contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vector Biosystems, Inc. (doing business as Vector Biolabs), a minority-owned and small disadvantaged for-profit biotechnology company. The $10,870.00 contract is for the delivery of adeno-associated viruses (AAVs) to express mitochondrial and cytosolic-targeted reactive oxygen species (ROS) sensitive proteins. This will support...
- This federal contract award was made by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the U.S. Department of Health and Human Services (HHS), to Vector Biosystems, Inc. (doing business as Vector Biolabs), a minority-owned, self-certified small disadvantaged biotechnology company located in Malvern, Pennsylvania. The $6,230 firm-fixed-price contract was awarded on March 12, 2010 for the delivery of a KI vector constructed with interleukin-17A (IL-17A)....
- The National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, awarded a $15,238 firm fixed price purchase order to Vectorbuilder Inc. for AAV8 large-scale 10 and ultra-purification packaging services. The contract has an ultimate completion date of August 26, 2025. Vectorbuilder is a specialized biotechnology company that provides gene delivery and molecular biology services to various federal agencies, including the Department of Veterans Affairs...
- This firm fixed-price contract for $803,500.00 was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Vector Biomed Inc. for the production and stability testing of clinical grade lentiviral vector. The services include manufacturing a minimum of 50mg of GMP/clinical grade transfer plasmid and 400ml of concentrated, GMP grade lentiviral vector, as well as performing stability testing...
- Vectorbuilder Inc. has been awarded a firm fixed price purchase order in the amount of $11,437 by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to provide custom adeno-associated virus packaging. No set-aside designation was applied to this procurement. Per the award description, Vectorbuilder will deliver molecular cloning services to support the NIDDK's biomedical research efforts. As a global leader in gene delivery technologies,...
- The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded a $16,999 firm fixed-price purchase order to Vectorbuilder Inc., a specialized biotechnology company, for large-scale 15 and ultra-purification packaging service for PAAV240227-1016XNQ. The contract, which does not utilize any set-aside designations, has a completion date of September 3, 2025. Vectorbuilder, a global leader in gene delivery...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $664,000.65 firm fixed price purchase order to Vigene Biosciences, Inc., a minority-owned small business, for the delivery of clinical grade virus vectors. The award was made through a sole source acquisition process under Federal Acquisition Regulation (FAR) Part 12 for commercial items. The vectors are needed to support ongoing research at NIAID's Laboratory...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation...
This federal contract award, valued at $10,600.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The contract was awarded to Vector Biosystems, Inc., doing business as Vector Biolabs, a minority-owned, small disadvantaged biotechnology company that provides gene delivery products and services. The contract is for the delivery of an AAV8-SPC512-MCHERRY construct, which is likely a gene therapy product containing a specific adeno-associated virus (AAV) vector encoding a fluorescent reporter gene. This contract supports NCATS' initiatives in gene therapy research and development. The contract was awarded on a firm fixed price basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 8/1/24 |